What is a stock summary page? Click here for an overview.
New Key Statistics Module, Z-Score and F-Score
NAS:ARWR Key Ratios
| Market Cap $ M | 1,656.05 |
| Enterprise Value $ M | 1,718.38 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 28.71 |
| Price/Sales | 603.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 2.00 |
| EPS (TTM) $ | -5.16 |
| Beneish M-Score | -17.74 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.86 |
| EV-to-EBITDA | -2.96 |
| PEG | -- |
| Shares Outstanding M | 137.32 |
| Net Margin (%) | -25,588.56 |
| Operating Margin % | -25,037.88 |
| Pre-tax Margin (%) | -25,955.44 |
| Quick Ratio | 6.09 |
| Current Ratio | 6.09 |
| ROA % (ttm) | -69.25 |
| ROE % (ttm) | -263.74 |
| ROIC % (ttm) | -145.40 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.78 |
ARWR Number of Guru Trades
ARWR Volume of Guru Trades
Gurus Latest Trades with NAS:ARWR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ARWR is held by these investors
Total 2
Arrowhead Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:ARWR
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers